Advances in Managing Infections in Lung Transplantation: A Review


Abstract
300 2663
Advances in Managing Infections in Lung Transplantation: A Reviewby
![]() ![]() Abstract Transplanted lung allografts are particularly susceptible to infection among SOT due to the constant exposure to the environment, aggressive immunosuppressive strategies, and impaired clearance mechanisms after denervation of the transplanted lung. Though prophylactic antimicrobial, anti [...] 300 2663 |
Frequency of Unplanned Readmissions Following Lung Transplantation During the SAR-COV-2 Pandemic When Hospital Resources Were Strainedby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Despite the concerted efforts by lung transplant recipients (LTR) and their medical teams, hospital readmissions are common in the first year following transplantation. Reasons for unplanned readmissions include allograft rejection, infections, and respiratory failure before the SARS-COV [...] 519 2895 |
Low Mortality Associated with COVID-19 Infection in Lung Transplant Recipients at a Single Centerby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Lung Transplant Recipients (LTR) are particularly vulnerable to severe infection, hospitalization, and death due to community acquired respiratory viruses. As a result, the global SARS-Cov-2 pandemic poses a higher risk to this population. We aim to study the lung function, severity of i [...] 378 2895 |
Contribution of a Single Islet Transplant Program to Basic Researchers in North America, Europe, and Asia through Distributing Human Isletsby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract There has been a steady expansion in islet isolation and transplantation activity worldwide. In addition to preparing human islets for transplantation, we have been providing human islets to basic researchers. The aim of this study was to review the activity of distribution of human isle [...] 505 3934 |
Thrombotic Microangiopathy in Solid Organ Transplantationby
![]() ![]() ![]() ![]() ![]() ![]() Abstract Thrombotic Microangiopathy (TMA) is a syndrome characterized by microangiopathic hemolytic anemia (MAHA) and thrombocytopenia. The presence of schistocytes on peripheral smear, a negative Coombs test, elevated lactate dehydrogenase, increased reticulocyte count and low haptoglobin are often the clue [...] 480 3901 |
Management of Steatosis in Living Donors: Where Do We Stand?Abstract With the progressive rise in rates of liver transplantation, stagnant donor pool, and social factors, living donor liver transplantation (LDLT) forms the majority of liver transplantations performed in Asian countries. As the global prevalence of metabolic-associated fatty liver disease (MAFLD) is i [...] 412 2969 |
Airway Complications after Lung TransplantationAbstract Lung transplantation in patients with end stage lung disease can improve survival and quality of life. Airway complication incidence varies between 2-33%, but the true incidence is difficult to determine due to a lack of validated classification systems. There are many risk factors for post lung tra [...] 415 3205 |
Calculated Human Leucocyte Antigens Evolutionary Divergence (cHED)by
![]() Abstract Human Leucocyte Antigens (HLA) constitute a highly polymorphic set of genes pivotal to the immune response. The HLA heterozygous advantage hypothesis assumes that heterozygous individuals at the HLA level have a wider range of peptides for T cell recognition than homozygous individuals. Consequently [...] 378 2917 |
Chronic Lung Allograft Dysfunction, a Review in 2023Abstract Chronic allograft dysfunction (CLAD) is one of the leading causes of death after lung transplantation [1]. CLAD is a progressive and irreversible decline in lung function after transplant, manifested as an obstructive, restrictive, or mixed ventilatory impairment without any identifiable [...] 496 4173 |
Evaluation of Total Parenteral Nutrition in the Autologous Transplantation Setting in Patients with AML: A Retrospective Exploratory Analysisby
![]() ![]() ![]() ![]() ![]() ![]() Abstract Malnutrition remains a clinical challenge in AML patients undergoing autologous hematopoietic stem cell transplantation (ASCT), leading to physical deconditioning and prolonged hospitalization. Prospective data are mainly lacking to identify those patients who may particularly benefit from parentera [...] 529 3251 |